1 / 12

Presented by Carinne Meyer, MA, MPH

Non-Pneumatic Anti-Shock Garment (NASG) POPPHI 2009 Update Suellen Miller, CNM, PhD Director, Safe Motherhood Programs, Bixby Center for Global Reproductive Health, UCSF. Presented by Carinne Meyer, MA, MPH. The NASG: Low-cost, Low Tech Life Saving Device. Update on Research.

yuki
Download Presentation

Presented by Carinne Meyer, MA, MPH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Non-Pneumatic Anti-Shock Garment (NASG)POPPHI 2009 Update Suellen Miller, CNM, PhDDirector, Safe Motherhood Programs, Bixby Center for Global Reproductive Health, UCSF Presented by Carinne Meyer, MA, MPH

  2. The NASG: Low-cost, Low Tech Life Saving Device

  3. Update on Research • Nigeria: Pre-Post Study (Completed) • Egypt:Pre-Post Study (Completed) • Zambia/Zimbabwe: Cluster Randomized Trial (In Progress)

  4. Nigeria Study (Mar. 04 – Nov. 08) • Pre-intervention/intervention study design • 12 referral hospitals in Northern and Southern Nigeria • Entry criteria were OH of any etiology (> = 750 ml) and one clinical sign of shock. • Outcomes: mean measured blood loss and mortality.

  5. Ongoing Collaboration

  6. Egypt Study (June 06 – May 08) • Pre-intervention/intervention study design • 2 referral facilities in Egypt • Entry criteria were OH of any etiology (> = 750 ml) and one clinical sign of shock. • Outcomes: mean measured blood loss, mortality, severe morbidities and extreme adverse outcomes.

  7. Zambia/Zimbabwe RCT Design: Cluster Randomized Trial Funding: NIH and Gates Foundation Data Coordination: WHO, RHRU Data Management: Centro Rosario Estudios Perinatales (CREP) (Argentina) OpenClinica Research Collaboration: University Teaching Hospital in Lusaka, Zambia and the University of Zimbabwe (UZ-UCSF RH Collaborative)

  8. Why a RCT? The RCT is designed to determine if early application at the primary care level by midwives will IMPROVE MATERNAL OUTCOMES.

  9. Randomized Cluster Trial Clinics Referral Hospital

  10. Study Design – Example Lusaka

  11. Study Timeline LUSAKA – Phase 1 LUSAKA – Phase 2 LUSAKA – Phase 3 May 2009 October 2009 October 2007 October 2008 June 2008 July 2009 Feb 2009 HARARE – Phase 1 HARARE – Phase 2 HARARE – Phase 3 COPPERBELT– Phase 1 COPPERBELT– Phase 2 COPPERBELT– Phase 3

  12. Thank You.

More Related